Both in Surgical Instruments
MiMedx Group vs Neuropace
Over the past year MDXG returned −56.8% and NPCE returned +31.0%; their daily moves had a correlation of 0.24.
MDXG −56.8% NPCE +31.0%Growth of $1, one year, split-adjusted
| Metric | MDXG | NPCE |
|---|---|---|
| Price | $3.25 | $12.31 |
| Market cap | $474.3M | $422.5M |
| Today | −0.91% | −0.24% |
| 1 month | −28.6% | −6.9% |
| 6 months | −10.7% | −27.8% |
| Year to date | −52.0% | −20.3% |
| 1 year | −57.5% | +23.8% |
| Revenue growth (YoY) | −45.2% | +17.1% |
| Gross margin | 79.8% | 82.8% |
| Net margin | −13.9% | −27.2% |
| P/E (TTM) | — | — |
| Price / sales | 1.6× | 4.3× |
| Net cash | $120.8M | -$7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | 40.2% |
| Short % of float | 8.1% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).